Back to Trades
Gline Matthew
CEODirectorCIK 0001750094
Total Volume
$203.0M
7 filings
Purchases
$50.0K
1 buy txns
Sales
$46.2M
4 sell txns
Net Activity
-$46.1M
net sold
Profile
- Filings
- 7
- Buy transactions
- 1
- Sell transactions
- 4
- Companies
- 1
- Active
- 2025–2026
Gline Matthew, CEO, Director, has filed 7 SEC reports (2025–2026), all concentrated in Roivant Sciences Ltd. (ROIV), totaling $203.0M in disclosed volume. Weighing $50.0K bought versus $46.2M sold, the history is heavily weighted toward selling. The largest single open-market purchase on record is $50.0K in Roivant Sciences Ltd.. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
7 loaded
| Oct 20 | ROIV Roivant Sciences Ltd. | Gline Matthew | CEO, Director | Tax withheld | $1.2M |
| Oct 2 | ROIV Roivant Sciences Ltd. | Gline Matthew | Insider | Tax withheld | $2.8M |
| Jul 2 | ROIV Roivant Sciences Ltd. | Gline Matthew | CEO, Director | Tax withheld | $2.7M |
| Apr 20 | ROIV Roivant Sciences Ltd. | Gline Matthew | CEO, Director | Sell | $8.4M |
| Apr 1 | ROIV Roivant Sciences Ltd. | Gline Matthew | CEO, Director | Exercise | $9.9M |
| Dec 17 | ROIV Roivant Sciences Ltd. | Gline Matthew | Insider | Sell | $37.7M |
| Sep 18 | ROIV Roivant Sciences Ltd. | Gline Matthew | Insider | Buy | $50.0K |
7 filings